| Name | Title | Contact Details |
|---|
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
AOS Research Services is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since 1996, Principals of Clearwater Living have been actively engaged in the ownership, operation, and development of high-quality senior living communities nationwide. More specifically, the Principals of Clearwater have been an integral part of creating various senior living platforms for operators as part of senior management. In 2011, Clearwater Living was formed for the sole purpose of providing entitled land and developing senior living communities for operators and their financial stakeholders. By combining best practices learned and aligning with top-of-class industry professionals, Clearwater Living`s primary objective is to expedite the process of supplying innovative projects to meet the growing demand of active adult and senior living communities. To further that goal, Clearwater Living and Berkshire Group entered into a joint venture in 2016. Through the joint venture, Clearwater Living will strategically acquire, develop and operate a full range of senior housing communities (including a mix of active adult, independent living, assisted living and memory care) throughout the Western United States. CWL is comprised of a high-performance real estate team utilizing our collective imagination, ingenuity and inventiveness in everything we do. Our passion is to create and manage high-quality senior living communities uniquely positioned and designed to complement their community and neighborhood culture.
Pacific Pulmonary Services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Novato, CA. To find more information about Pacific Pulmonary Services, please visit www.ppsc.com
BloodSource is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sacramento, CA. To find more information about BloodSource, please visit www.bloodsource.org